Description:
Investment Partner Sponsor
Investment partner Sponsor
Session Sponsor
Session Sponsor
Session Sponsor
Summit Dinner Sponsor
Session Sponsor
Cocktail Function Sponsor
Session Sponsor
Session Sponsor
2025 Bioshares Biotech Summit
The 19th Bioshares Biotech Summit was held in Hobart this year with 232 attendees, and more than 35 companies presented.
Congratulations to the Dimerix team for winning the Blake Award for Excellence for the second year running, after securing four regional partnering deals in the last two years with $67 million in upfronts already received.
Next year's Summit will return to Queenstown! We will let you know dates once finalised.
Presentations from BBS2025
Presentations from this year's Summit will be made available below once clearance has been received.
- Syntara, Gary Phillips
- Invion, Thian Chew
- Dimerix, Nina Webster
- Clinuvel Pharmaceuticals, Lachlan Hay
- Amplia Therapeutics, Chris Burns
- Cynata Therapeutics, Kilian Kelly
- Actinogen Medical, Steven Gourlay
- Tryptamine Therapeutics, Jason Carroll
- Artrya, John Konstantopoulos
- Argenica, Liz Dallimore
- Nyrada, James Bonnar
- Chimeric Therapeutics, Rebecca McQualter
- Neuren Pharmaceuticals, Jon Pilcher
- Investment Panel Stock Tips for Next 12 Months
- Minomic, Brad Walsh
- Starpharma, Cheryl Maley
- Bell Potter Securities (contact Thomas Wakim)
- Micro-X, Kingsley Hall
- Cartherics, Ian Nisbet
- Clever Culture Systems, Brent Barnes
- Myopharm, Karinza Phoenix
- Lateral Pharma, David Kenley
- Tetratherix, Will Knox
- ImmVirX, Malcolm McColl
- HaemaLogiX, Damian Clarke-Bruce
- QBiotics, Stephen Doyle
- Navier Medical, Sander Bangma
The Bioshares Team
